Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Treace Medical Concepts (TMCI) Short-term Investments (2022 - 2025)

Treace Medical Concepts (TMCI) has disclosed Short-term Investments for 3 consecutive years, with $64.3 million as the latest value for Q4 2024.

  • For the quarter ending Q4 2024, Short-term Investments fell 41.64% year-over-year to $64.3 million, compared with a TTM value of $64.3 million through Dec 2024, down 41.64%, and an annual FY2024 reading of $64.3 million, down 41.64% over the prior year.
  • Short-term Investments was $64.3 million for Q4 2024 at Treace Medical Concepts, down from $70.7 million in the prior quarter.
  • Across five years, Short-term Investments topped out at $114.9 million in Q3 2023 and bottomed at $61.8 million in Q4 2022.
  • Average Short-term Investments over 3 years is $87.1 million, with a median of $85.7 million recorded in 2024.
  • The sharpest move saw Short-term Investments surged 78.4% in 2023, then plummeted 41.64% in 2024.
  • Year by year, Short-term Investments stood at $61.8 million in 2022, then soared by 78.4% to $110.2 million in 2023, then tumbled by 41.64% to $64.3 million in 2024.
  • Business Quant data shows Short-term Investments for TMCI at $64.3 million in Q4 2024, $70.7 million in Q3 2024, and $100.7 million in Q1 2024.